PVT1 and neoplasm: We found that lowering PVT1 resulted in reduced proliferation (MTT assay - P < 0.0001), migration potential of the tumor cells (transwell migration assay–P = 0.003) and clonogenic survival (P = 0.0088) in SK-OV3 (Fig 4C–E).